Health and medtech companies were always vital, but they emerged to be one of the most focused segments in 2020. This year, the spotlight is around medtech startups as we start our journey to recover from the COVID-19 pandemic. UK-based healthtech startup Huma is now in the limelight for securing a notable £91.88 million in its latest funding round.
Bigwigs fund Huma
The current funding round for Huma was led by some well-known companies. Bayer’s Leaps and Hitachi Ventures led the Series C funding round for the company. Samsung Next, Sony Innovation Fund by IGV, Unilever Ventures and HAT Technology & Innovation Fund, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) also invested in the company to become new shareholders.
Goldman Sachs International acted as lead placement agent to Huma while HSBC Bank pl and Nomura acted as joint placement agents, with the latter also becoming a new shareholder in the company. There’s also an additional £49.47 million that can be availed later as part of Series C funding round, and it takes the total financing raised to more than £140 million. ...